PANC Stock Chart & Stats
$0.05
$0.00(0.00%)
At close: 4:00 PM EST
$0.05
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.05 - $0.05
Previous CloseN/A
Volume120.00
Average Volume (3M)0.00
Market Cap
$54.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding53,640,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PANC FAQ
What was Panacos Pharmaceuticals Inc’s price range in the past 12 months?
Panacos Pharmaceuticals Inc lowest stock price was $0.05 and its highest was $0.05 in the past 12 months.
What is Panacos Pharmaceuticals Inc’s market cap?
Panacos Pharmaceuticals Inc’s market cap is $54.00.
When is Panacos Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Panacos Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is Panacos Pharmaceuticals Inc overvalued?
According to Wall Street analysts Panacos Pharmaceuticals Inc’s price is currently Overvalued.
Does Panacos Pharmaceuticals Inc pay dividends?
Panacos Pharmaceuticals Inc does not currently pay dividends.
What is Panacos Pharmaceuticals Inc’s EPS estimate?
Panacos Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Panacos Pharmaceuticals Inc have?
Panacos Pharmaceuticals Inc has 53,640,000 shares outstanding.
What happened to Panacos Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Panacos Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in PANC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Panacos Pharmaceuticals Inc
Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm specializing in the research and development of orally administered small-molecule therapeutics. These innovative drugs are crafted to combat human immunodeficiency virus (HIV) and various other viral diseases affecting humans. The company's scientific methodology concentrates on identifying novel targets within the viral life cycle, specifically focusing on processes like virus maturation and fusion. Currently, their product portfolio includes advanced initiatives, such as second- and third-generation programs, centered on inhibiting HIV maturation. Founded in 1999, the company's main operations are situated in Watertown, Massachusetts.
Technical Analysis
―
Enveric Biosciences
―
Aditxt
―
Dermata Therapeutics
―
Virax Biolabs Group Ltd. Class A
―